The effects of drugs on wound healing: Part 1

International Journal of Dermatology

Volumn 39, Issue 4, 2000, Pages 250-257

  Karukonda, Sree R K ^a   Flynn, Timothy Corcoran ^a   Boh, Erin E ^a   McBurney, Elizabeth I ^a   Russo, Glenn G ^a   Millikan, Larry E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; ASCORBIC ACID; COLCHICINE; CORTICOSTEROID; CYTOKINE; DAPSONE; EPIDERMAL GROWTH FACTOR; ERYTHROMYCIN; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INTERFERON; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TETRACYCLINE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASOCONSTRICTOR AGENT;

BLOOD CLOTTING; HUMAN; INFLAMMATION; INJURY; REVIEW; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME; WOUND HEALING;

CYTOKINES; HUMANS; WOUND HEALING;

EID: 0034098136     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00948.x     Document Type: Review

References (84)

1. Bernstein E. Wound healing. Clin Dermatol 1994; 12: 1-191.
2. Falanga V, Zitelli JA, Eaglstein WH. Periodic synopsis wound healing. J Am Acad Dermatol 1988; 19: 559-562.
3. Telfer NR Moy RL. Drug and nutrient aspects of wound healing. Dermatol Clin 1993; 11: 729-737.
4. Hom DB, Szachowicz EH (guest editors). Wound healing for the otolaryngologist - head and neck surgeon. Otolaryngol Clin North Am 1995; 28: 835-1091.
5. Koopman CF Jr, Chvapil M (guest editors). Symposium on wound healing. Otolaryngol Clin North Am 1984; 17: 243-453.
6. Nemeth AJ. Wound healing. Dermatol Clin 1993; 11: 783-789.
7. Zitelli J. Wound healing for the clinician. Adv Dermatol 1987; 2: 243-268.
8. Hunt TK, ed. Wound Healing and Wound Infection: Theory and Surgical Practice. New York: Appleton-Century-Crofts, 1977: 1-10.
9. Clark RAF. Cutaneous tissue repair: basic biologic considerations part I. J Am Acad Dermatol 1985; 13: 701-725.
10. Hunt TK. Basic principles of wound healing. J Trauma 1990; 30: S122-S128.
11. Fine NA, Mustoe TA. Wound healing. In: Greenfield LI, editor-in-chief. Surgery. Scientific Principles and Practice, 2nd edn. Philadelphia: Lippincott, 1997: 67-83.
12. Cohen IK, Diegelmann RF, Crossland MC. Wound care and wound healing. In: Schwartz SI, editor-in-chief, 6th edn. Principles of Surgery. New York: McGraw-Hill, 1994: 279-303.
13. Clark RAF. Mechanisms of cutaneous wound repair. In: Fitzpatrick TB, Eisen AZ, Wolff, et al., Dermatology in General Medicine, Vol. 1. New York: McGraw-Hill, 1993: 473-486.
14. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin 1993; 11: 629-640.
15. Rothe MJ, Falanga V. Growth factors and wound healing. Clin Dermatol 1992; 9: 533-559.
16. Elias PM, Jackson SM. What does normal skin do? In: Arndt KA, Robinson JK, Le Boit PE, Wintroub BU, eds. Cutaneous Medicine and Surgery. Philadelphia: W.B. Saunders, 1996: 46-57.
17. Ongenae KC, Phillips TJ. Leg ulcers and wound healing. In: Arndt KA, Robinson JK, Le Boit PE, Wintroub BU, eds. Cutaneous Medicine and Surgery, Vol. 1. Philadelphia: W.B. Saunders, 1996: 558-573.
18. Zitelli JA. Wound healing by first and second intention. In: Roenigk RK, Roenigk HH, eds. Dermatologic Surgery. Principles and Practice, 2nd edn. New York: Marcel Dekker, 1996: 101-130.
19. Leibovitch SJ, Ross R. The role of macrophages in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
20. Riches DWH. The multiple roles of macrophages in wound healing. In: Clark RAF, Henson PM, eds. Molecular and Cellular Biology of Wound Repair. New York: Plenum, 1988: 213.
21. Simpson DM, Ross R. The neutrophilic leukocyte in wound healing: a study with antineutrophilic serum. J Clin Invest 1972; 51: 2009-2023.
22. Shimakado K, Raines EW, Madtes DK, et al. A significant part of macrophage-derived growth factor consists of two forms of PDGF. Cell 1985; 43: 277-286.
23. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-6024.
24. Baird A, Mormede P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage growth factor. Biochem Biophys Res Commun 1985; 126: 358-364.
25. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor-α in activated human alveolar macrophages. Cell 1988; 53: 285-293.
26. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413-1418.
27. Winter GD. Epidermal regeneration studied in the domestic pig. In: Maibach HI, Rovee DT, eds. Epidermal Wound Healing. Chicago: Yearbook, 1972: 71.
28. Krawczyk WS. A pattern of epidermal cell migration during wound healing. J Cell Biol 1971; 49: 247-253.
29. Burgess AW. Epidermal growth factor and transforming growth factor alpha. Br Med Bull 1989; 45: 401-424.
30. Hom DB. Growth factors in wound healing. Otolaryngol Clin North Am 1995; 28: 933-953.
31. McGrath MH, Hundahl SA. The spatial and temporal quantification of myofibroblasts. Plast Reconstr Surg 1982; 69: 975-985.
32. Singer II, Kawka DW, Kazazis DM, Clark RAF. In vivo codistribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 1984; 98: 2091-2106.
33. Gabbiani G, Hirschel BJ, Ryan GB, et al. Granulation tissue as a contractile organ: a study of structure and function. J Exp Med 1972; 135: 719-734.
34. Montesano R, Orci L. Transforming growth factor beta stimulates collagen matrix contraction by fibroblasts: implication for wound healing. Proc Natl Acad Sci USA 1988; 85: 4894-4897.
35. Hunt TK, Goodson WH. Wound healing. In: Way LW, ed. Current Surgical Diagnosis and Treatment, 9th edn. Norwalk, CT: Appleton & Lange, 1991: 95-108.
36. Diegelmann RF, Rothkopf LC, Cohen IK. Measurement of collagen biosynthesis during wound healing. J Surg Res 1975; 19: 239-243.
37. Clark RAF. ed. The Molecular and Cellular Biology of Wound Repair, 2nd edn. New York: Plenum, 1996: 1-611.
38. Lawrence WT, Diegelmann RF. Growth factors in wound healing. Clin Dermatol 1994; 12: 157-169.
39. Robson MC. Exogenous growth factor application effect on human wound healing. Prog Dermatol 1996; 30: 1-7.
40. Katz MH, Alvarez AF, Krisner, RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991; 25: 1054-1058.
41. Duel TF, Kawahra RS, Mustoe TA, Pierce GF. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Ann Rev Med 1991; 42: 567-584.
42. King LE, Carpenter GF. Epidermal growth factor. In: Goldsmith LA, ed. Biochemistry and Physiology of the Skin. New York: Oxford University Press, 1983: 269-281.
43. Greenhalgh DG, Rieman M. The effect of bFGF on the healing of partial thickness skin graft donor sites. A prospective randomized, double-blind study. Wound Rep Reg 1994; 2: 113-121.
44. Lees VC, Fan TP. A freeze-injured skin graft model for the quantitative study of basic fibroblast growth factor and other promoters of angiogenesis in normal healing. Br J Plast Surg 1994; 47: 349-359.
45. Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Rep Reg 1993; 1: 181-186.
46. Bucalo B, Eaglstein WH, Falanga V. The effect of chronic wound fluid on cell proliferation in vitro (abstr). J Invest Dermatol 1989; 92: 408.
47. Grinell F, Ho CH, Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting and cell adhesion assays. J Invest Dermatol 1992; 98: 410-416.
48. Vandeberg JS, Robson MC, Mihail RJ. Extension of life span of pressure ulcer fibroblasts with recombinant human interleukin-1B. Am J Pathol 1995; 146: 1273-1282.
49. Mustoe TA, Cutler NR, Allman RM, et al. Phase II study to evaluate recombinant PDGF-BB in the treatment of pressure sores. Arch Surg 1994; 129: 213-219.
50. Robson MC, Phillips LG, Lawrence WT, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992; 216: 401-408.
51. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993; 166: 74-81.
52. Falanga V, Eaglstein WH, Bucalo B, et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Oncol 1992; 18: 604-606.
53. Robson MC, Phillips LG, Cooper DM. The safety and effect of transforming growth factor-B2 for the treatment of venous stasis ulcers. Wound Rep Reg 1995; 3: 157-167.
54. Mustoe TA, Ahn ST, Tarpley JE, et al. Role of hypoxia in growth factor responses: differential effects of basic fibroblast growth factor and platelet derived growth factor in an ischemic wound model. Wound Rep Reg 1994; 2: 227-283.
55. Steed DL. The Diabetic Ulcer Study Group: clinical evaluation of recombinant human platelet growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995; 21: 71-81.
56. Steed DL, Ricotta J, Prendergast JJ, et al. Promotion and acceleration of diabetic ulcer healing by RGD peptide matrix. Diabetic Care 1995; 18: 39-46.
57. Reed BR, Clark RAF. Cutaneous tissue repair: practical implications of current knowledge II. J Am Acad Dermatol 1985; 13: 919-941.
58. Clark RAF, Gallin JI, Fauci AS. Effect of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. Blood 1979; 53: 633-641.
59. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978; 70: 51-55.
60. Eady EA, Holland KT, Cunliffe WJ. The use of antibiotics in acne therapy: oral or topical administration? J Antimicrob Chemother 1982; 10: 89-115.
61. Dahl MV. Clinical Immunodermatology, 3rd edn. St Louis: Mosby, 1996.
62. Flower RJ, Moncada S, Vane JR. Analgesics, antipyretics and anti-inflammatory agents: drugs employed in gout. In: Gilman LS, Gilman A, eds. The Pharmacologic Basis of Therapeutics. New York: Macmillan, 1980: 718-720.
63. Hirschman JV. Topical antibiotics in dermatology. Arch Dermatol 1988; 124: 1691-1700.
64. Custer J, Edlishc R, Prusak M, et al. Studies in the management of the contaminated wound. Am J Surg 1971; 121: 572-575.
65. Camisa C, Eisenstat B, Ragaz A, Weissmann G. The effects of retinoids on neutrophil function in vitro. J Am Acad Dermatol 1982; 6: 620-629.
66. Ballin A, Leong I, Carter DM. Effect of mupirocin on the growth and lifespan of human fibroblasts. J Invest Dermatol 1987; 88: 736.
67. Ehrlick HP, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968; 167: 324-328.
68. Bauer EA, Valle KJ. Colchicine-induced modulation of collagenase in human skin fibroblast cultures: I. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol 1982; 79: 398-403.
69. Hunt TK, Dunphy JE. Fundamentals of Wound Management. New York: Appleton-Century-Crofts, 1979; 103-107.
70. Eisen AZ, Goldberg GI. The role of extracellular matrix metalloproteinase inhibitors in connective tissue remodeling. In: Fitzpatrick TB, Eisen AZ, Wolff, et al., Dermatology in General Medicine, 4th edn, Vol. 1. New York: McGraw-Hill, 1993: 315-328.
71. Mussini E, Hutton JJ Jr, Udenfriend S. Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science 1967; 157: 927-929.
72. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 1986; 314: 892-902.
73. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1995. A 72-year old man with exertional dyspnea, fatigue, and extensive ecchymoses and purpuric lesion. N Engl J Med 1995; 333: 1695-1702.
74. Jorizzo JO, Callen JP. Dermatologic manifestations of internal disease. In: Arndt KA, Robinson JK, Le Boit PE, Wintroub BU, eds. Cutaneous Medicine and Surgery. Philadelphia: W.B. Saunders, 1996: 1863-1888.
75. Benveniste K, Thut P. The effect of chronic alcoholism on wound healing. Proc Soc Exp Biol Med 1981; 166: 568-575.
76. Hohn DC. Host resistance to infections: established and emerging concepts. In: Hunt TK, ed. Wound Healing and Wound Infection: Theory and Surgical Practice. New York: Appleton-Century-Crofts, 1980: 264-279.
77. Pai MP, Hunt TK. The effect of varying oxygen tensions on healing open wounds. Surg Gynecol Obstet 1972; 135: 756-758.
78. Niinikoski J. The effect of blood and oxygen supply on the biochemistry of repair. In: Hunt TK, ed. Wound Healing and Wound Infection, New York: Appleton-Century-Crofts, 1980: 56-71.
79. Golsen JB. Wound healing for the dermatologic surgeon. J Dermatol Surg Oncol 1988; 14: 959-972.
80. Krizek TH, Robson MC. Evolution of quantitative bacteriology in wound management. Am J Surg 1975; 130: 579-584.
81. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.
82. Hinman CD, Maibach MI, Winter CD. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 377-379.
83. Dyson M, Young SR, Penele L, et al. Comparison of moist and dry conditions on dermal repair. J Invest Dermatol 1989; 92: 434-439.
84. Dyson M, Yung SR, Hart J, et al. Comparison of moist and dry conditions on the process of angiogenesis during dermal repair. J Invest Dermatol 1992; 99: 729-733.